DIAGNOS Announces the Extension Term of Warrants

DIAGNOS Announces the Extension Term of Warrants

ID: 205989

(firmenpresse) - BROSSARD, QUEBEC, CANADA -- (Marketwire) -- 11/21/12 -- DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces today an extension of 15 months to the term for exercise of the eligible warrants issued as part of the most recent private placement.

The original term was November 26, 2012. With the extension of 15 months, the eligible outstanding warrants are now exercisable up to February 26, 2014 (the "Expiry date"). Each warrant entitles its holder to acquire one common share at an unchanged price of $0.40 up to the Expiry date. As initially stated, each warrant carries a forced conversion feature as such that should the common shares of the Corporation trade at or above $0.60 for twenty consecutive trading days at any time up to the Expiry date, then all of the warrants shall be exercised within 30 days or they will automatically expire.

The amendment to warrant term is subject to TSX Venture acceptance.

All monies quoted in this press release shall be stated in lawful money of Canada.

About DIAGNOS

Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE: ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources.

For further information, please visit our website at or the SEDAR website at .

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:
Andre Larente, President
DIAGNOS inc.
450-678-8882


Louis Morin
Bid Capital Markets




514-845-1101

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Mirada Medical Presents Multi-Modal Quantitative Reading Exhibit at the RSNA Annual Meeting VIQ Solutions Reports Third Quarter 2012 Results
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 21.11.2012 - 21:01 Uhr
Sprache: Deutsch
News-ID 205989
Anzahl Zeichen: 0

contact information:
Town:

BROSSARD, QUEBEC, CANADA



Kategorie:

Software



Diese Pressemitteilung wurde bisher 186 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"DIAGNOS Announces the Extension Term of Warrants"
steht unter der journalistisch-redaktionellen Verantwortung von

DIAGNOS Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

DIAGNOS Closes Second Tranche of Private Placement ...

BROSSARD, QUEBEC -- (Marketwired) -- 10/23/17 -- DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, ...

Alle Meldungen von DIAGNOS Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z